Table 1.
Clinical characteristics of the pooled clinical trial sample and independent qualitative interview sample
| Characteristic | Pooled trial sample (N = 2147) | Independent qualitative sample (N = 20) |
|---|---|---|
| n (%) | n (%) | |
| Age category | ||
| <65 | 742 (34.6) | 11 (55.0) |
| ≥65‐<74 | 1013 (47.2) | 5 (25.0) |
| ≥75 | 392 (18.3) | 4 (20.0) |
| Sex | ||
| Male | 1111 (51.7) | 11 (55.0) |
| Female | 1036 (48.3) | 9 (45.0) |
| Race | ||
| White | 1719 (80.1) | 16 (80.0) |
| Black or African American | 35 (1.6) | 3 (15.0) |
| Asian | 285 (13.3) | 1 (5.0) |
| American Indian or Alaska Native | 4 (0.2) | ‐ |
| Other/Unknown/Multiple | 30 (1.4) | ‐ |
| Missing | 74 (3.4) | ‐ |
| Education | ||
| Some high school | ‐ | 1 (5.0) |
| High school diploma | ‐ | 4 (20.0) |
| Some years at college | ‐ | 5 (25.0) |
| College or university degree | ‐ | 8 (40.0) |
| Masters degree | ‐ | 1 (5.0) |
| Doctorate degree | ‐ | 1 (5.0) |
| Region | ||
| Europe | 1464 (68.2) | 2 (10.0) |
| North America | 236 (11.0) | 18 (90.0) |
| Rest of World | 447 (20.8) | |
| MM type | ||
| Relapsed/refractory | 1421 (66.2) | 10 (50.0) |
| Newly diagnosed | 726 (33.8) | 10 (50.0) |